"Advancing science for the benefit of patients."
Haiming obtained both his B.S. and M.S. degrees from the University of Science and Technology of China and his Ph.D. from Iowa State University under the direction of Prof. Richard Larock. He then did two years of postdoc with Prof. Brian Stoltz at Caltech working on CH Functionalization chemistry and total synthesis of natural product Telomestatin. Haiming started his industrial career at Lexicon Pharmaceuticals in Princeton NJ in 2005 and moved to Genentech in 2010. He is currently a Sr. Pr. Scientist and Group Leader in the Small Molecule Process Chemistry department at Genentech.
Int. Ed. 2020, 59, 2844.
Org. Chem. 2019, 84, 4796.
J. Am. Chem. Soc. 2018, 140, 10109.
Process Res. Dev. 2018, 22, 978.
Org. Lett. 2017, 19, 6212.
J. Am. Chem. Soc. 2017, 139, 12181.
J. Am. Chem. Soc. 2017, 139, 10777.
Strategic planning, route scouting and process development of various small molecule development candidates ranging from LSR to Ph3.